$3.10
-0.01-0.32%
Last update: Sep 20, 6:20 PM
15 minutes delayed
Evaxion Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Evaxion Biotech using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.12 | $-0.39 | 69.2 % |
Mar 2024 | 2024-05-28 | $0.03 | $-0.56 | 105.4 % |
Dec 2023 | 2024-03-27 | $-1.60 | $-1.60 | 0.00 % |
Sep 2023 | 2023-12-19 | $-2.10 | $-1.90 | -10.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $154.00K | $30.00K | 413.3 % |
Mar 2024 | 2024-05-28 | $51.00K | $37.00K | 37.8 % |
Evaxion Biotech (EVAX) is scheduled to report earnings on December 17, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.12, which beat the estimate of $-0.39.
The Actual Revenue was $154K, which beat the estimate of $30K.
Browse earnings estimates, EPS, and revenue on all stocks.